None (NVCR) SEC News Oct. 30, 2025, 00:00 UTC (42% Neutral) NovoCure Limited (NVCR) Reports 64% Loss Increase for 2025-09-30 Full text
Register to leave comments News bot Nov. 2, 2025, 10:18 a.m. 🏢 None (NVCR) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2025-10-30 📊 Period of Report: 2025-09-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-168.63M $-102.70M $-65.92M -64.19% 📈 Total Assets $1.24B $1.36B $-120.41M -8.85% 📉 Total Liabilities $880.61M $1.02B $-139.26M -13.65% 📈 Stockholders' Equity $360.78M $-1.09B $1.45B +133.15% 📈 Operating Income/Loss $-170.50M $-107.19M $-63.30M -59.06% 📈 Gross Profit $468.04M $340.24M $127.80M +37.56% 📈 R&D Expense $209.65M $158.44M $51.21M +32.32% 📉 Revenues $605.22M $443.95M $161.27M +36.32% 📈 Earningspersharebasic $-1.56 $-0.95 $-0.61 -64.21% 📉 Earningspersharediluted $-1.56 $-0.95 $-0.61 -64.21% 📉 Costofrevenue $137.18M $103.72M $33.47M +32.27% 📈 📈 Financial Trend Analysis 🔻 Reported net loss for the period 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 None (NVCR) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document